Hutch News
Results per Page:
Injectable HIV drug prevents infections
Early data shows fewer infections than with daily pill; trial halted
Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success
Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
SCHARP played key role in scientific breakthrough of the year
Science magazine selected HIV prevention trial for its top honor of 2011; study showed early antiretroviral therapy reduced heterosexual HIV transmission by 96 percent
Initiation of antiretroviral treatment protects partners from HIV infection
Supported by SCHARP’s data management, HIV Prevention Trials Network shows 96 percent reduction in HIV transmission to uninfected sexual partners
Faculty profile: Biostatistics and real world solutions
VIDI’s Elizabeth Brown studies mother-to-child transmission of HIV and more to make a difference in peoples’ lives